INTRODUCTION
Early events in the retroviral life cycle are dependent on the virus-associated enzyme reverse transcriptase (RT), which copies the viral RNA genome to form a double-stranded proviral DNA (for a review, see Varmus and Swanstrom, 1982) . The RT associated with murine leukaemia virus (MuLV) has been purified and has been shown to be a monomer of relative molecular mass about 70000-80000 (Gerard and Grandgenett, 1975; Verma, 1975) . The primary amino acid sequence of MuLV-RT was deduced from the complete nucleotide sequence of the proviral DNA (Shinnick et al., 1981) . The gene coding for MuLV-RT has been cloned into a number of expression vectors (Kotewicz et al., 1985; Roth et al., 1985) , and the protein has been purified to homogeneity. The cloned protein, of Mr 71 000, enables the study of structure-function relationships in this class of enzymes. There is a significant primary sequence similarity amongst all the known retroviral RTs (Johnson et al., 1986) . By comparison of RT sequences with other DNA polymerases and with RNAase Hs, it was suggested that in all RTs the DNA polymerase and RNAase H domains are distinct from each other and joined together by tether sequences. Although all RTs characterized so far are multifunctional enzymes and have a similar domain organization, they differ significantly in their subunit organization, catalytic properties and patterns of inhibition by different drugs (Gerard and Grandgenett, 1980; Verma, 1981; Hizi et al., 1988) . The enzyme from one system, therefore, may not always serve as a model for other systems. The threedimensional structure of human immunodeficiency virus-i (HIV1)-RT has been deciphered recently (Kohlstaedt et al., 1992) , but, due to significant differences between HIV1-RT and primer or primer alone in the modification mixture protected only Cys-90 from modification by benzophenone 4-maleimide. To investigate the role of Cys-90 in detail, we converted it to alanine by site-directed mutagenesis. The mutant enzyme, however, exhibited no loss either of DNA polymerase or of RNAase H activity. These results indicate that Cys-90 is located in a domain of murine leukaemia virus reverse transcriptase that binds template-primer, but may not have a direct role in the enzymic function ofthe enzyme. Ala-90 mutant murine leukaemia virus reverse transcriptase is at least 10-fold more susceptible to heat inactivation than is the wild-type enzyme, which suggests that Cys-90 in murine leukaemia virus reverse transcriptase may play a role in maintaining structural integrity.
MuLV-RT, the structure of HIV1-RT cannot be extrapolated directly to MuLV-RT. MuLV-RT is active as a monomer, and the catalytic domains (DNA polymerase and RNAase H) are totally independent of each other (Kotewicz et al., 1988; Tanese and Goff, 1988; Hizi et al., 1990) . However, HIV1-RT is active only as a dimer (Basu et al., 1992b) , and there is a significant interaction between the two catalytic domains (Hizi et al., 1988; Prasad and Goff, 1989; Hizi et al., 1991) .
In an attempt to understand the enzymic mechanisms and structure-function relationships of MuLV-RT, our laboratory has, over the past few years, carried out chemical modification studies, u.v.-mediated cross-linking ofsubstrates and site-directed mutagenesis to identify domains and residues that are important for catalysis. For example, covalent modification with pyridoxal phosphate and subsequent site-directed mutagenesis (Basu et al., 1990) has revealed Lys-103 to be one of the residues that are involved in substrate dNTP binding. U.v.-mediated cross-linking with oligo(dT)8 has enabled us to identify residues 72-80 as forming a part of the primer-binding domain (Tirumalai and Modak, 1991) . Ferrate ion-mediated oxidation of MuLV-RT has revealed a number of domains that are important for the template-primer binding function of this enzyme (Reddy et al., 1991) .
All known RTs, except those of HIVI and HIV2, are relatively rich in cysteine residues; MuLV-RT has eight cysteines, while avian myeloblastosis virus (AMV)-RT has twelve in the 1991, 1992). However, identification of sulphydryl groups and the elucidation of the importance of individual sulphydryl groups in the process of catalysis has not been reported. In this study, we have used a sulphydryl-group-specific bifunctional reagent, benzophenone 4-maleimide (BP-MAL), to identify cysteine residues in MuLV-RT, and to show that Cys-90 and Cys-310 are selectively modified by BP-MAL. A detailed characterization of the chemically modified enzyme implied that the domain containing Cys-90 was important in binding template-primer. Sitedirected mutagenesis of Cys-90, however, indicated no direct role for cysteine in the catalysis. This paper gives the results of this investigation and discusses possible implications for the role of Cys-90 in MuLV-RT.
MATERIALS AND METHODS
All synthetic template-primers and non-radioactive NTPs were obtained from PL Biochemicals. Trifluoroacetic acid (TFA), formamide and dithiothreitol (DTT) were from Sigma. Acetonitrile and h.p.l.c.-grade water were from Fisher Scientific Co. Trypsin (Tos-Phe-CH2Cl-treated) was obtained from Worthington. BP-MAL was obtained from Molecular Probes (Junction City, OR, U.S.A.). All other chemicals were of analytical grade. MuLV-RT was purified essentially as described previously (Roth et al., 1985) from an Escherichia coli strain containing the plasmid pRT601, which codes for an RT of Mr 71000.
[3H](rA) . (dT). was synthesized and purified as described previously (Reddy et al., 1991) .
Enzyme assays DNA polymerase assay The DNA polymerase activity of MuLV-RT was determined using synthetic template-primers as described previously (A. .
RNAase H assay
The RNAase H activity of MuLV-RT was measured by using tritium-labelled (rA).* (dT). as the substrate. The reaction mixture contained 50 mM Hepes/KOH, pH 7.8, 1 mM DTT, 20 mM NaCl, 10 ,tg of BSA, 1 mM MnCl2, 0.5 ,ug of [3H](rA)n (dT).
(specific radioactivity 20000 c.p.m.) and 100 ng of enzyme in a final volume of 100 ,l. The reactions were carried out at 37°C for 30 min, and acid-insoluble counts were determined.
Inactivation of MuLV-RT with BP-MAL
All the reactions were carried out in the dark as BP-MAL is a photolabile reagent. MuLV-RT (adjusted to 140 ,ug/ml) in 50 mM Hepes/KOH, pH 7.8, 20 mM NaCl and 10 % (v/v) 
Cross-linking studies
To examine whether the modification of MuLV-RT by BP-MAL led to its inability to bind to template-primer, the extent of u.v.-mediated cross-linking of native and BP-MAL-modified enzyme to radiolabelled template-primer was determined. For cross-linking, 2 sg of the enzyme was incubated on ice for 15 min with 0.5 ,ug (0.5 ,uCi) of labelled template-primer {poly(dA) [32P](dT)15} or of primer {5'[32P](dT)15} in 30 ,d1 of buffer containing 50 mM Hepes/KOH, pH 7.8, 20 mM NaCl, 10 % (v/v) glycerol, 1 mM DTT and 1 mM EDTA. The reaction mixture was then exposed to u.v. irradiation at a dose of 4 x 10-4 J/mm2 in a spectrolinker XL-1000 u.v. cross-linker (manufactured by Spectronics Corporation, Chestnut Hill, MA, U.S.A.). The u.v.-cross-linked enzyme species were analysed by SDS/PAGE. To measure the extent of cross-linking the radioactive bands were excised and dried, and the associated radioactivity was quantified by liquid-scintillation spectroscopy.
Protein chemistry of BP-MAL-modffled MuLV-RT For peptide analyses, 2 nmol of the enzyme was modified with BP-MAL as described above. The protein was precipitated with 10 % (v/v) trichloroacetic acid (TCA) and collected by centrifugation at 10000 g for 10 min at 4 'C. The precipitate was washed with 5 % (v/v) cold TCA (until there was no trace of BP-MAL in the washings), water and alcohol, and finally was dried under vacuum. The pellet was solubilized in 25 ,1 of 8 M urea and then diluted to 200 ,ul with 100 mM ammonium bicarbonate, pH 8.0. Trypsin (Tos-Phe-CH2CI-treated) was then added at a protein: trypsin ratio of 50: 1, and the mixture incubated at 37 'C. After 2 h, another aliquot of trypsin (50: 1 protein: trypsin) was added and the incubation continued overnight. The tryptic digests were directly loaded on to a Vydac C-18 reverse-phase column (0.45 cm x 25 cm, 5 ,tm particle size, 30 nm pore size) that had been pre-equilibrated with 0.1 % TFA (solvent A). Peptides were eluted by increasing the concentration of 70 % (v/v) acetonitrile containing 0.1 % TFA (solvent B) as described previously . The peptides of interest were dried in vacuum, redissolved in 200 ,ul of 0.1 % TFA and further purified on a Vydac C-18 column using shallow gradients of solvent B for peptide elution (see the legend to Figure 4 for details).
Amino acid analysis Purified peptides were hydrolysed in 6 M HCI containing 0.2 % phenol for 16 h at 115 'C in a Waters Pico-tag work-station. The resulting amino acids were converted to their phenylthiocarbamyl derivatives with phenyl isothiocyanate and analysed by h.p.l.c. using Waters Nova-pak columns (two 0.45 cm x 15 cm columns attached in series) by the method described by Stone and Williams (1986) .
Site-directed mutagenesis Mutagenesis of codon-90 of MuLV-RT from cysteine to alanine was done using PCR. Two oligonucleotides corresponding to nucleotides 257-278 and 1089-1108 in the MuLV-RT sequence were synthesized chemically and used as primers for the PCR. The first oligonucleotide is a 22meric product with the sequence 5'-TACTGGTACCCGCCCCAGTCCC-3' that contained the desired mutation (underlined). It also contains a naturally occurring KpnI site (GGTACC). The second oligonucleotide, 5'-GTAGCCTGCTTCTCGTCGAC-3', was 81 1 bases downstream from the 3' end of the first oliognucleotide and is complementary for 15 min on ice before adding BP-MAL.
to the coding sequence. Plasmid pB6B 15.23 containing the entire sequence of MuLV-RT (Roth et al., 1985) was linearized by digesting with BglII and 20 cycles of PCR were performed using the above oligonucleotides. The amplified DNA (850 bp) was purified, cleaved with KpnI and Sall and cloned into the expression vector pB6BI5.23. The entire inserted region was sequenced by the dideoxy method to confirm that no change in the MuLV-RT sequence had occurred except for the desired mutation. The mutant protein was expressed and purified as described previously (Basu et al., 1990) . Table 2 Properties of BP-MAL inactivation of MuLV-RT MuLV-RT (1 ug) was treated with 0.5 mM BP-MAL for the desired period of time as described in the legend to (Table 2 ). The pattern of inhibition observed with BP-MAL was quite similar to that observed with N-ethylmaleimide on AMV-RT (Gorecki and Panet, 1978) and on MuLV-RT (Hizi et al., 1991) .
Mode of Inactivation
Studies with various sulphydryl reagents have suggested that the polymerase activity of AMV-RT is dependent on the presence of reduced sulphydryl groups. Competition experiments with substrate dNTP or with template-primer (Gorecki and Panet, 1978; Parnaik and Das, 1981) and direct substrate-binding assays (Srivastava et al., 1983) have suggested that the cysteine sulphydryl groups of AMV-RT are involved in the process of template-primer binding. Similar studies were carried out to determine the mode of action of BP-MAL on MuLV-RT.
Lineweaver-Burk analysis of competition between (rA)n * (dT)15
and inhibitor, as well as dNTP and inhibitor, is shown in Figure 1 .
The results indicate clearly that BP-MAL is competing directly with the template-primer-binding site of MuLV-RT. To emphasize this point further, the protective effects of various substrates of the DNA polymerization reaction on BP-MALmediated inactivation were measured. The results, shown in Table 3 et , 1989 Mohan et al., 1988) . Thus, to identify the domain(s) in the enzyme molecule containing the BP-MAL-reactive cysteine residue(s) that interacts with the template-primer, we resorted to comparative tryptic-peptide mapping. Figure 4 shows the reverse-phase tryptic-peptide maps, on a Vydac C-18 reverse-phase column, of native enzyme, BP-MAL-modified enzyme and enzyme modified with BP-MAL in the presence of template-primer or of primer alone. The BP-MAL-modified peptides were located by the appearance of new peptides in the map of BP-MAL-modified enzyme and by their characteristic absorption spectra (see Figure 3b) . Of the two BP-MAL-modified peptides, only peptide 2, eluting after about 119 min, was found to be specifically protected from BP-MAL when the modification was carried out in the presence of template-primer or primer alone (Figure 4c ). To characterize the BP-MAL-modified peptides, both peptides 1 and 2 ( Figure 4) were purified further by rechromatography on a C-18 column using a shallow gradient of acetonitrile (Figure 3) , and subjected to amino acid composition analysis. The amino acid composition of peptides 1 and 2, as shown in Table 4 , revealed them to span residues 302-311 and 81-102 respectively, in the primary amino acid sequence of MuLV-RT (Copeland et al., 1985) . Both the peptides contain one cysteine residue and, since maleimide has high specificity towards sulphydryl groups at neutral pH (Partis et al., 1983) , we conclude that Cys-310 in peptide 1 and Cys-90 in peptide 2 are the sites of modification. The high specificity of the maleimide group of BP-MAL towards cysteine residues has been noted in a number of other proteins. For example, Cys-98 of troponin and Cys-190 of tropomyosin (Tao et al., 1986) , and Cys-697 of myosin (Agarwal et al., 1991) were found to be modified specifically by BP-MAL. Since only peptide 2, containing Cys-90, was specifically protected by template-primer from BP-MAL modification, we conclude that Cys-90 lies in a domain that is important in binding template-primer.
Site-directed mutagenesis of Cys-90
The above results have indicated that the domain containing Cys-90 is important in binding primer in MuLV-RT. Reduced cysteine residues are known to be involved directly in binding nucleotides in tubulin (Little and Luduena, 1987) and in the gene 5 protein of fd phage (Paradiso and Konigsberg, 1982) . Thus, to see if the -SH group of Cys-90 in MuLV-RT is directly involved in nucleotide binding, we mutated Cys-90 to Ala by site-directed mutagenesis. The mutant protein was purified and its identity checked by Western-blot analysis using a monoclonal antibody raised against pure viral enzyme (the antibody was a generous gift from Dr. S. Goff of Columbia University, New York), as described previously (Basu et al., 1990) . We then compared the overall catalytic activities of the wild-type and of the mutant enzyme. It is apparent from See Figure 4 . The numbers given represent residues in the primary amino acid sequence of MuLV-RT (Copeland et al., 1985) . polymerase activity. Under the experimental conditions used, the half-life of the wild-type enzyme at 50°C was about 210 min, while that of the mutant enzyme was only 20 min. Heat stability Determination of the stability of enzymes at elevated temperatures is commonly used to study the structural differences between related proteins (Hizi and Joklik, 1977; Hizi et al., 1991) and between mutant proteins (Polesky et al., 1990; Loya et al., 1992) . Since the mutation of Cys-90 to Ala did not change the catalytic activity of MuLV-RT significantly, we tried to determine whether this mutation resulted in any structural change. (Gerard and Grandgenett, 1980; Verma, 1981; Goff, 1990) . To map the important cysteine residues in MuLV-RT, we have used a cysteine-specific reagent, BP-MAL. This reagent was selected for a number of reasons. BP-MAL, unlike N-ethylmaleimide, has been shown to react rapidly and with high specificity with sulphydryl residues in a number of proteins (Tao et al., 1986; Rajasekharan et al., 1987; Agarwal et al., 1991) . This reagent has a high molar extinction coefficient (6280 13000 M-' cm-') (Tao et al., 1985) and therefore provides a useful tag to monitor the site of labelling. Finally, the benzophenone moiety is a photoreactive group that can be used to cross-link and so identify residue(s) within 0.3-0.4 nm of the sulphydryl groups. The detailed analysis presented here shows that BP-MAL reacts with two cysteine residues in MuLV-RT, and inactivates the DNA polymerase activity of MuLV-RT. The enzyme inactivation is attributed further to the inability of the BP-MAL-modified enzyme to bind to the template-primer and, more specifically, to the primer moiety (Figure 4) It is important to point out that the domain containing Cys-90 in MuLV-RT is part of a unique secondary structure that is composed of two polypeptide double helices on both sides of an anti-parallel sequential dimer (Gerard et al., 1986) . Such structures have been proposed to be involved in nucleic-acid binding in many proteins (Jurnak, 1985) . In addition, the proximity of this domain to Lys-103, which has been implicated in dNTP binding (A. Basu et al., , 1990 , would be favourable for phosphodiester-bond formation. The proximity of the dNTPand primer-binding domains has been well-documented in the case of E. coli DNA polymerase I (Basu and Modak, 1987; Catalano et al., 1990; Polesky et al., 1990; Rush and Konigsberg, 1990; Yadav et al., 1992) .
To determine whether Cys-90 is directly involved we mutated this residue to alanine and compared the catalytic properties of the mutant enzyme with that of the wild-type enzyme. The Cys-90-+Ala mutation had no effect on the DNA polymerase activity nor on the RNAase H activity (Table 5) . Thus, the results from mutation do not confirm the conclusion drawn from the results of chemical modification. Taken together, these results suggest that the side-chain of Cys-90 may not directly interact with the polynucleotide substrate, but may be located within its binding domain. The enzyme inactivation following chemical modification may be explained as follows. The addition of a bulky benzophenone moiety to Cys-90, which is in the molecular proximity of the primer-binding domain, can render the enzyme inactive by physically interfering with the binding of the primer. The primer-cross-linking studies support this idea (Figure 2) .
It is possible that Cys-90 and other cysteine residues in MuLV-RT may have some role in maintaining the overall structural integrity of the enzyme. To test this hypothesis, the thermal stability of the mutant enzyme was compared with that of the wild-type enzyme. The wild-type enzyme was found to be about 10-fold more stable than the mutant enzyme at 50 'C. It is not clear at present how a single mutation can affect the heat stability so markedly. A drastic change in the heat-stability patterns of the wild-type and mutant proteins has also been observed for HIVI-RT (Loya et al., 1992) .
The role of Cys-310, which reacts with BP-MAL as efficiently as does Cys-90, is not very clear, but its location in the threedimensional structure may be inferred to be distal to the template-primer-and substrate-binding domains. In summary, Cys-90 in MuLV-RT appears to be in or near the active-site cleft, but it does not participate in the catalytic function. It appears that Cys-90 of MuLV-RT and possibly other cysteine residues in this class of enzymes may be required to maintain the structural integrity of the polymerase domain of the enzyme molecule.
